Neuromyelitis Optica Spectrum Disorders in North Indian Population: Experience from a Tertiary Care Center

被引:3
|
作者
Sachdeva, Julie [1 ]
Goyal, Manoj K. [1 ]
Singh, Ramandeep [2 ]
Kapila, Aastha T. [1 ]
Singh, Paramjeet [3 ]
Saikia, Biman [4 ]
Lal, Vivek [1 ]
机构
[1] PGIMER, Dept Neurol, Chandigarh, India
[2] PGIMER, Dept Ophthalmol, Chandigarh, India
[3] PGIMER, Dept Radiodiag & Intervent Radiol, Chandigarh, India
[4] PGIMER, Dept Immunopathol, Chandigarh, India
关键词
Neuromyelitis optica; North Indian; NMOSD; AQUAPORIN; 4; AQP4; MOG;
D O I
10.4103/0028-3886.355118
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction: To understand neuromyelitis optica spectrum disorders (NMOSDs) better we need to study them in different populations. This prospective study was conducted to characterize clinical, serological, radiological, and therapeutic profile of NMOSDs in a North Indian population. Materials and Methods: This study included 81 patients with NMOSDs. All patients underwent detailed history and examinations and were followed at 3 monthly intervals. They were evaluated using standard investigations including gadolinium-enhanced magnetic resonance imaging (MRI) of the brain and spine with thin section optic nerve cuts and treated as per the standard guidelines. Data were recorded meticulously. Results: The mean age was 33.7 +/- 13.4 years. The mean age at disease onset was 31.2 +/- 13.5 years. Female-to-male ratio was 1.9:1. About 32.1% of patients presented with optic neuritis (ON), 56.8% with transverse myelitis (TM), and 11.1% with both ON and TM. The mean time from disease onset to diagnosis was 16.17 +/- 23.09 months. Muscle atrophy, Lhermitte symptom, and tonic spasms were common. Foster-Kennedy syndrome-like presentation was seen in 8.6%. NMO antibodies were positive in 41 patients. MRI revealed involvement of <4 vertebral segments in 16.4% of patients with TM. Patients were managed as per standard guidelines. The mean follow-up duration was 15.3 +/- 6 months. Approximately 88.9% had good functional outcome. Conclusion: NMOSDs are a common cause of demyelinating illnesses in Northern India. The response to treatment is excellent and most patients recover without residual disability.
引用
收藏
页码:1500 / 1505
页数:6
相关论文
共 50 条
  • [21] Effectiveness of subcutaneous tocilizumab in neuromyelitis optica spectrum disorders
    Lotan, Itay
    Charlson, Robert W.
    Ryerson, Lana Zhovtis
    Levy, Michael
    Kister, Ilya
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 39
  • [22] Neuromyelitis optica spectrum disorders and pregnancy: Interactions and management
    Shosha, Eslam
    Pittock, Sean J.
    Flanagan, Eoin
    Weinshenker, Brian G.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (14) : 1808 - 1817
  • [23] Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders
    Abboud, Hesham
    Salazar-Camelo, Andrea
    George, Naveen
    Planchon, Sarah M.
    Matiello, Marcelo
    Mealy, Maureen A.
    Goodman, Andrew
    JOURNAL OF NEUROLOGY, 2022, 269 (04) : 1786 - 1801
  • [24] Paths to hippocampal damage in neuromyelitis optica spectrum disorders
    Zakani, Mona
    Nigritinou, Magdalini
    Ponleitner, Markus
    Takai, Yoshiki
    Hofmann, Daniel
    Hillebrand, Sophie
    Hoeftberger, Romana
    Bauer, Jan
    Lasztoczi, Balint
    Misu, Tatsuro
    Kasprian, Gregor
    Rommer, Paulus
    Bradl, Monika
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2023, 49 (02)
  • [25] Perspectives on Neuromyelitis Optica Spectrum Disorders, the Narrative Medicine contribution to care
    Filippi, Massimo
    Borriello, Giovanna
    Patti, Francesco
    Inglese, Matilde
    Trojano, Maria
    Marinelli, Fabiana
    Chisari, Clara
    Iaffaldano, Pietro
    Zanetta, Chiara
    Chesi, Paola
    Termini, Roberta
    Marini, Maria Giulia
    NEUROLOGICAL SCIENCES, 2024, 45 (04) : 1589 - 1597
  • [26] Perspectives on Neuromyelitis Optica Spectrum Disorders, the Narrative Medicine contribution to care
    Massimo Filippi
    Giovanna Borriello
    Francesco Patti
    Matilde Inglese
    Maria Trojano
    Fabiana Marinelli
    Clara Chisari
    Pietro Iaffaldano
    Chiara Zanetta
    Paola Chesi
    Roberta Termini
    Maria Giulia Marini
    Neurological Sciences, 2024, 45 : 1589 - 1597
  • [27] Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies
    Contentti, Edgar Carnero
    Correale, Jorge
    JOURNAL OF NEUROINFLAMMATION, 2021, 18 (01)
  • [28] Late Onset of Neuromyelitis Optica Spectrum Disorders
    Fragoso, Yara Dadalti
    Ruocco, Heloisa Helena
    Dias, Ronaldo Maciel
    Cabeca, Hideraldo
    Goncalves, Ricardo
    de Carvalho Sousa, Nise A.
    Spessotto, Caroline Vieira
    Tauil, Carlos Bernardo
    Alves-Leon, Soniza Vieira
    Gomes, Sidney
    Goncalves, Marcus Vinicius M.
    Nunes Machado, Suzana C.
    Anacleto, Andrea
    Correa, Eber Castro
    Pimentel, Maria Lucia V.
    Santos, Gutemberg Augusto C.
    NEUROLOGY AND THERAPY, 2019, 8 (02) : 477 - 482
  • [29] Neuromyelitis optica spectrum disorders - laboratory examination
    Nytrova, P.
    Kral, V
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 : S31 - S36
  • [30] Editorial: Advances in neuromyelitis optica spectrum disorders
    Cai, Yu
    Burton, Jodie M.
    Shi, Fu-Dong
    Qiu, Wei
    Guan, Yangtai
    FRONTIERS IN NEUROLOGY, 2022, 13